Last throw of the dice: PGM has only enough money left for a...

Last throw of the dice: PGM has only enough money left for a year tops. They cannot be paying much for the study as they have not got much to pay. Unless they can get a boost from the scoping study, they are looking at a CR at 3 cents or less. More losses for us patient shareholders. And what are they raising on? They seem to be ignoring the Owendake project (and talking crazily IMO) of a new project. Just release the scoping study, already. It is just an update of years of work, including some expensive drilling, so ger on with it. And let us poor shareholders hold or fold in peace.